Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2020; 17(12):1795-1802. doi:10.7150/ijms.47546 This issue Cite

Research Paper

Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures

Dongli Li1,2, Yuran Ma1, Wenfeng Liu1, Xiang Ren1, Min Chen1, Xuetao Xu1, Zhaojun Sheng1, Kun Zhang1,2, Renping Zhou3, Susan Goodin4, Xi Zheng1,3✉

1. School of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
2. International Healthcare Innovation Institute (Jiangmen), Jiangmen city, Guangdong Province 529020, China.
3. Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
4. Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA.

✉ Corresponding author: Xi Zheng Ph.D Email: xizhengrutgers.edu; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854. Phone: 848-445-8069; Fax: 732-445-0687.

Citation:
Li D, Ma Y, Liu W, Ren X, Chen M, Xu X, Sheng Z, Zhang K, Zhou R, Goodin S, Zheng X. Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. Int J Med Sci 2020; 17(12):1795-1802. doi:10.7150/ijms.47546. https://www.medsci.org/v17p1795.htm
Other styles

File import instruction

Abstract

Background/Aim: Pancreatic adenocarcinoma is a highly malignant tumor. Synergistic combinations of anticancer agents for the effective treatment of pancreatic cancer patients are urgently needed. Here, we investigated the combined effect of celecoxib (CEL) and salirasib (SAL) on pancreatic cancer cells.

Methods: Cell viability and apoptosis were measured by the trypan blue assay, three-dimensional cultures, propidium iodide staining, and caspase-3 assay. NF-κB activation and the protein levels of Akt, pAkt, and Bcl-2 were determined by the luciferase reporter assay and western blot.

Results: Co-treatment with CEL and SAL had stronger effects on decreasing cell viability and inducing apoptosis in Panc-1 cells as compared with each agent individually. This combination strongly inhibited NF-κB activity and reduced pAkt and Bcl-2 levels in Panc-1 cells.

Conclusion: SAL in combination with CEL may represent a new approach for effective inhibition of pancreatic cancer.

Keywords: Pancreatic cancer, 3D cultures, celecoxib, salirasib, NF-κB.

Citation styles

APA
Li, D., Ma, Y., Liu, W., Ren, X., Chen, M., Xu, X., Sheng, Z., Zhang, K., Zhou, R., Goodin, S., Zheng, X. (2020). Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. International Journal of Medical Sciences, 17(12), 1795-1802. https://doi.org/10.7150/ijms.47546.

ACS
Li, D.; Ma, Y.; Liu, W.; Ren, X.; Chen, M.; Xu, X.; Sheng, Z.; Zhang, K.; Zhou, R.; Goodin, S.; Zheng, X. Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. Int. J. Med. Sci. 2020, 17 (12), 1795-1802. DOI: 10.7150/ijms.47546.

NLM
Li D, Ma Y, Liu W, Ren X, Chen M, Xu X, Sheng Z, Zhang K, Zhou R, Goodin S, Zheng X. Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. Int J Med Sci 2020; 17(12):1795-1802. doi:10.7150/ijms.47546. https://www.medsci.org/v17p1795.htm

CSE
Li D, Ma Y, Liu W, Ren X, Chen M, Xu X, Sheng Z, Zhang K, Zhou R, Goodin S, Zheng X. 2020. Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. Int J Med Sci. 17(12):1795-1802.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use